
Allozen Pharma Private Limited
Pharmaceutical company manufacturing and selling various healthcare products, drugs, and instruments.
Pharmaceutical company manufacturing and selling various healthcare products, drugs, and instruments.
Allozen Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 October 2019 (Five years and five months 27 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹49.40 Cr.
Atish Jain and Prafful Jain serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
U24290KA2019PTC128784
128784
Private Limited Indian Non-Government Company
16 Oct 2019
30 Sep 2024
31 Mar 2024
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Atish Jain ![]() | Director | 01-Oct-2022 | Current |
Prafful Jain ![]() | Director | 16-Oct-2019 | Current |
Allozen Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.91% increase. The company also saw a substantial fall in profitability, with a 49.85% decrease in profit. The company's net worth Soared by an impressive increase of 25.31%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Allozen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Atish Jain is a mutual person
Prafful Jain is a mutual person
₹49.40 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
01 Feb 2025 | Others | ₹25.00 Cr | Open |
26 Oct 2024 | Hdfc Bank Limited | ₹2.00 M | Open |
30 Jun 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹14.00 Cr | Open |
30 Jun 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.00 M | Open |
27 Feb 2020 | Others | ₹10.00 Cr | Open |
Allozen Pharma has a workforce of 26 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Allozen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allozen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101047279 was registered on 01 Feb 2025.
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 101030446 was registered on 26 Oct 2024.
Allozen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Allozen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
A charge with Others of Rs. 10.00 Cr registered on 27 Feb 2020 with Charge ID 100327110 was modified on 19 Jun 2023.
Atish Ashok Jain was appointed as a Director was appointed as a Director on 01 Oct 2022 & has been associated with this company since 2 years 6 months .
Allozen Pharma Private Limited was incorporated on 16 Oct 2019.
The authorized share capital of Allozen Pharma Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 4.50 M.
Currently 2 directors are associated with Allozen Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Allozen Pharma Private Limited is No 49/3 Khata 191 Sreegandhada Kaval Sunkadakate Yeshwantapura Hobli, Magadi Road India, Bangalore, Karnataka, 560091.
The corporate identification number (CIN) of Allozen Pharma Private Limited is U24290KA2019PTC128784 and the company number is 128784 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Allozen Pharma Private Limited has risen by 25.91%.
As Per 2023 financial reports, 26 employees are currently employed by Allozen Pharma Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Allozen Pharma Private Limited has experienced an upsurge of 25.31%.
As per the financial statements for fiscal Year 2023, The total open charges for Allozen Pharma Private Limited amount to ₹ 49.40 Cr.
The most recent Balance Sheet for Allozen Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
DJ
AP